NCT01613131 - Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Menopausal and Other Perimenopausal Disorders

Interventions

DRUG

Mirena

Mirena (levonorgestrel-releasing intrauterine system), 52 mg (20 mcg/day), 5 year duration (study duration 6 months).

DRUG

Estradiol

Topical, .06%, Applied once daily for 50 days.

DRUG

Placebo Gel

Topical Gel, Applied once daily for 50 days, Placebo comparator.

Trial Locations (1)

University of Colorado, Aurora